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OBJECTIVE — To evaluate the frequency of foot prevention strategies among high-risk pa-
tients with diabetes.
RESEARCH DESIGN AND METHODS — Electronic medical records were used to
identify 150 patients on dialysis and 150 patients with previous foot ulceration or amputation
with 30 months follow-up to determine the frequency with which patients received education,
podiatry care, and therapeutic shoes and insoles as prevention services.
RESULTS — Few patients had formal education (1.3%), therapeutic shoes/insoles (7%), or
preventativepodiatriccare(30%).Theulcerincidencedensitywasthesameinbothgroups(210
per1,000person-years).Incontrast,theamputationincidencedensitywashigherinthedialysis
groupcomparedwiththeulcergroup(58.7vs.13.1per1,000person-years,P0.001).Patients
on dialysis were younger and more likely to be of non-Hispanic white descent (P  0.006) than
patients with a previous history of ulcer or amputation.
CONCLUSIONS — Prevention services are infrequently provided to high-risk patients.
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T
he prevalence of foot complications
is 250% higher among dialysis-
treatedpatientsthanamongpatients
without chronic kidney disease (1–3).
Similarly, patients with a past ulcer his-
tory have a 34-times-greater risk of devel-
oping another ulcer (4,5). Programs to
prevent foot ulcers and amputations gen-
erally involve therapeutic shoes and in-
soles, regular foot care, and patient
education (6–8). This study evaluated
the frequency of prevention services
among high-risk patients.
RESEARCH DESIGN AND
METHODS— We used claims data
for diabetes (ICD-9 250.X), ulceration
(ICD-9707.10,707.14,and707.15),and
dialysis (CPT 90935–90937) from the
Scott and White Health Plan to identify
150 consecutive patients in each group
with at least 30 months follow-up from
the time of diagnosis. We enrolled sub-
jects from 2000 to 2006. We veriﬁed
thesediagnosesbyreviewingcomprehen-
sive electronic medical records (EMRs),
including all patient care notes, imaging,
labs,andprescriptions.ScottandWhiteis
an integrated, multispecialty physician
group with 550 physicians, 14 clinics,
three dialysis centers, and a 535-bed
hospital.
For the ulcer group, our evaluation
beganaftertheinitialulcerhealed.Forthe
dialysis group, our evaluation began with
the initiation of dialysis. Subjects with
HIV/AIDS,traumafrommotorvehicleac-
cidents, bilateral amputations, and pa-
tients with 30 months follow-up were
excluded.
Threepreventiontherapieswereeval-
uated: pedorthic care (professionally ﬁt-
ted therapeutic shoes and insoles),
diabeteseducation,andpodiatryservices.
Pedorthic services were identiﬁed from
notes in the EMRs and durable medical
equipment codes (codes A5501, A5503–
A5508, A5512, and A5513). Diabetes ed-
ucation was deﬁned as a session with a
certiﬁed diabetes educator (CPT codes
S9445, S9460, and S9465). Our diabetes
education program addressed “the dia-
betic foot” in the third of four education
sessions.Podiatrycarewasassessedbyre-
view of the EMRs to identify the number
of visits and determine whether the visit
was for prevention, ulcer treatment, or
other pathology. Foot assessment by any
health care provider was also identiﬁed.
Peripheral vascular disease was de-
ﬁned as at least two nonpalpable foot
pulses or abnormal ankle-brachial in-
dexes (0.9). Neuropathy was deﬁned as
at least one site insensate to a 10-g
Semmes-Weinstein monoﬁlament, ab-
normal vibration perception (25 volts),
or abnormal light-touch sensation. Pear-
son 
2 and Fisher exact tests were used to
compare categorical data between study
groups. Student t test was used to com-
pare continuous data.
RESULTS— We studied 300 patients
(dialysisgroup,n150;ulcergroup.n
150), and 92.3% had type 2 diabetes (Ta-
ble 1). Compared with the ulcer group,
dialysispatientswere10yearsyoungeron
average and less likely to be of Hispanic
(P  0.006) or African (P  0.001) de-
scent. The incidence of ulceration and
amputation was high in both study
groups. Incidence of ulceration was 210
per 1,000 person-years in both groups.
However, amputation incidence was sig-
niﬁcantly higher in the dialysis group
(58.7 vs. 13.1 per 1,000 person-years,
P  0.001).
Few patients received prevention ser-
vices (Table 1). Two patients (1.3%) in
thedialysisgrouphadformaldiabetesed-
ucation,andneitherattendedthediabetic
foot care session. No one in the ulcer
group received formal education. A small
proportion of patients received therapeu-
tic shoes. During the ﬁrst 12-month eval-
uation period, 21 patients (7%) received
shoes and insoles. Only four patients
(1.3%) received a second pair of thera-
peutic shoes and insoles during the sec-
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receivedathirdpairofshoesintheﬁnal6
months. There was no difference in the
proportion of patients that received ther-
apeuticshoesbetweenthedialysisandul-
cer groups (7.3 vs. 6.7%, P  1.0).
During the 30-month evaluation pe-
riod, 195 patients (65%) received care by
a podiatrist. However, the majority of pa-
tients (70%) were seen after they devel-
oped a foot ulcer. Only 90 patients (30%)
were seen for preventative care prior to
ulceration. Signiﬁcantly fewer patients in
the ulcer group were seen by a podiatrist
for preventative care (18%) compared
withthedialysisgroup(42%,P0.001).
Additionally, neuropathy (35%) and vas-
cular assessments (62.4%) were infre-
quently performed.
CONCLUSIONS — This study fo-
cused on two high-risk groups for devel-
oping diabetic foot ulcers and
amputations (1,9). As expected, the am-
putation incidence density was high in
both groups (ulcer group 13.1 and dialy-
sis group 58.7 per 1,000 person-years).
The amputation incidence in the general
population with diabetes ranges from 4.4
to 9.5 per 1,000 person-years (10).
Prevention services were infrequently
provided to patients in both risk groups.
Inourstudy,only7%ofpatientsreceived
therapeutic shoes, 1.3% received profes-
sional education, and 30% received pre-
ventative care by a podiatrist. Other
reports suggest a poor referral pattern for
therapeutic shoes as well. In a study by
Sugarmanetal.(11)only2.9%ofsubjects
with diabetes that met the criteria for
“high risk” received therapeutic foot-
wear. Although the high rate of ampu-
tation may be due to our study patients’
inherentriskforfootcomplications,itis
possible that poorly utilized prevention
services played a role. We expect that
appropriate prevention services could
have signiﬁcantly reduced the high rate
of amputation.
We believe the results of this study
can be generalized to high risk patients in
other health care settings. Perhaps, pre-
vention services would be provided less
frequently in community practices that
are not integrated and that do not have
electronic medical records because it is
more difﬁcult to communicate and coor-
dinate care.
Specialized diabetic foot programs
have been reported to reduce the inci-
dence of amputations by 50% (6–8).
Uccioli et al. (12) demonstrated 50%
reduction in foot ulceration when thera-
peutic shoes were prescribed for patients
with an ulcer history compared with pa-
tients that selected their own shoes, and
others have demonstrated that patients
receiving regular foot care have fewer re-
current ulcers (13).
Prevention services for the diabetic
foot are simple to establish and can be
made easily accessible through organized
multidisciplinary care. This data provide
further evidence that preventative foot
care is not regularly provided, even
among patients with the highest risk for
lower-limb complications. It also high-
lights an opportunity to improve preven-
tion services for the diabetic foot with
simple protocols for evaluation and
referral.
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